AbbVie Inc. enters the obesity market with GUBamy, a promising amylin analog. Click here to find out why ABBV stock is a Buy.

What Can We Expect From The Fed The Next Few Months? (12:30) - How Should You Position Your Portfolio Right Now? (17:40) - Top Stocks To Keep On Your Watchlist (28:30) - Episode Roundup: ABBV, XOM, ...

With Roche's latest deal, a new contender enters the obesity space, which could threaten NVO and LLY's dominance in the ...

NVO reports disappointing data from a phase III study on a novel obesity candidate, CagriSema. RHHBY buys rights to obesity candidate from Zealand Pharma.

Wearable and implantable biosensors that can accurately detect biological molecules in a non- or minimally invasive manner ...

After the surprising election, in which the social liberal party Demokraatit became the largest party, it is time for government negotiations in Greenland.And it will take time, is the general ...

Norwegian Airlines will open a new route between Billund and London Gatwick, according to Danish media outlet TV2. The Norwegian low-cost airline will also expand its routes between Billund and ...

But how do these microbial communities work? And can we harness their power to make agriculture more sustainable? These ...

The Novo Nordisk Foundation and University of Copenhagen researchers have backtracked over a project to redefine how the ...